Workforce of the Future Spotlighted at MS Conference Foundation of CMSC Presents Record Number of Scholars and Awardees (Hackensack, [...]
Genzyme’s Lemtrada Resubmission Accepted for Review by FDA - Agency action expected in Q4 2014 - Cambridge, Mass. - May 30, 2014 - [...]
Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses Friday, May 30, 2014 [...]
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Friday, May 30, 2014 Photos of the [...]
CMSC DAILY DIGEST: Official Reports from the 2014 Cooperative Meeting of CMSC and ACTRIMS Thursday, May 29, 2014 Photos of the [...]
Biogen Idec Announces Official Partnership with Sailing Sclerosis Oceans of Hope to Globally Change Perceptions of MS Wednesday, May [...]
EMD Serono Data at CMSC & ACTRIMS Annual Meeting Reinforces Proven Efficacy of Rebif® (interferon beta-1a) and Demonstrates Continued [...]
Contact: Annie Scully, 201-310-9252, annie.scully@mscare.org MEDIA ALERT Grow Your MS [...]
Acorda Therapeutics to Showcase Online Multiple Sclerosis Resources at 2014 CMSC/ACTRIMS Meeting 05/27/2014 The award-winning [...]
Genzyme Recognizes Sixth Annual World MS Day - Company Supporting Wide Range of Programs to Help Improve the Lives of People Living with [...]